ConductScience.org, home

Paper21178490

Ebolavirus VP35 is a multifunctional virulence factor.

Leung DW and 3 others. Virulence, 2010. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Ebolavirus VP35 is a multifunctional virulence factor. Papers, record 21178490. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21178490

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ebolavirus VP35 is a multifunctional virulence factor.
PubMed
Journal
Virulence
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.32
iCite
Revised in PubMed
2025-05-29
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Leung DWDaisy W
2Prins KCKathleen C
3Basler CFChristopher F
4Amarasinghe GKGaya K

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EbolavirusMajor topic
Immune EvasionMajor topic
InterferonsMajor topic
NucleoproteinsMajor topic
RNA, ViralMajor topic
Viral Core ProteinsMajor topic
Virulence FactorsMajor topic
Animals
Hemorrhagic Fever, Ebola
Humans
Immunity, Innate
Nucleocapsid Proteins
RNA, Double-Stranded
Signal Transduction

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI081914NIAID NIH HHSUnited StatesR01AI081914PubMed and NIHNIH RePORTER
R01AI059536NIAID NIH HHSUnited StatesR01AI059536PubMed and NIHNIH RePORTER
R56AI089547NIAID NIH HHSUnited StatesR56AI089547PubMed and NIHNIH RePORTER
U54 AI057160NIAID NIH HHSUnited StatesU54AI057160PubMed and NIHNIH RePORTER
R56 AI089547NIAID NIH HHSUnited StatesR56AI089547PubMed and NIHNIH RePORTER
F32 AI084324NIAID NIH HHSUnited StatesF32AI084324PubMed and NIHNIH RePORTER
R01AI081914NIAID NIH HHSUnited StatesR01AI081914PubMed and NIHNIH RePORTER
U54AI057160NIAID NIH HHSUnited StatesU54AI057160PubMed and NIHNIH RePORTER
R01 AI059536NIAID NIH HHSUnited StatesR01AI059536PubMed and NIHNIH RePORTER
U54 AI057158NIAID NIH HHSUnited StatesU54AI057158PubMed and NIHNIH RePORTER
AI057158NIAID NIH HHSUnited StatesU54AI057158PubMed and NIHNIH RePORTER
1F32AI084324NIAID NIH HHSUnited StatesF32AI084324PubMed and NIHNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117241710Status and challenges of filovirus vaccines.Vaccine2007https://conductscience.org/library/papers/17241710PubMed
219515768Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain.J Virol2009https://conductscience.org/library/papers/19515768PubMed
319694547Evasion of interferon responses by Ebola and Marburg viruses.J Interferon Cytokine Res2009https://conductscience.org/library/papers/19694547PubMed
419278996The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA.J Biol Chem2009https://conductscience.org/library/papers/19278996PubMed
519153231Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1.J Virol2009https://conductscience.org/library/papers/19153231PubMed
69765419Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes.J Virol1998https://conductscience.org/library/papers/9765419PubMed
720071589Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.J Virol2010https://conductscience.org/library/papers/20071589PubMed
816501110Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence.J Virol2006https://conductscience.org/library/papers/16501110PubMed
916095644Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein.Virology2005https://conductscience.org/library/papers/16095644PubMed
1015805739Nucleocapsid-like structures of Ebola virus reconstructed using electron tomography.J Vet Med Sci2005https://conductscience.org/library/papers/15805739PubMed
1117190786Antiviral signaling through pattern recognition receptors.J Biochem2007https://conductscience.org/library/papers/17190786PubMed
1219120476Approaching the RNA ligand for RIG-I?Immunol Rev2009https://conductscience.org/library/papers/19120476PubMed
1317118636Principles of intracellular viral recognition.Curr Opin Immunol2007https://conductscience.org/library/papers/17118636PubMed
1416698997Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.J Virol2006https://conductscience.org/library/papers/16698997PubMed
1512486817Viruses and the type I interferon antiviral system: induction and evasion.Int Rev Immunol2002https://conductscience.org/library/papers/12486817PubMed
1615383160Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.Expert Rev Mol Med2004https://conductscience.org/library/papers/15383160PubMed
1720018665Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20018665PubMed
1820081868Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.Nat Struct Mol Biol2010https://conductscience.org/library/papers/20081868PubMed
1916775331
Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.
J Virol2006https://conductscience.org/library/papers/16775331PubMed
209971816Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems.J Virol1999https://conductscience.org/library/papers/9971816PubMed

See all 39 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42943552Ebola Virus Persistence in Immune-Privileged Niches: Molecular Mechanisms, Host-Virus Interactions, and Therapeutic Opportunities.Microorganisms2026https://conductscience.org/library/papers/42943552PubMed
42726904Discovering host-viral protein interactions in autophagy: A LIR discovery pipeline for identifying LC3-interacting region motifs in highly virulent viruses.PLoS Pathog2026https://conductscience.org/library/papers/42726904PubMed
42579070Ebola virus disease in the modern era: pathogenesis, therapeutic advances, vaccine strategies, and global health preparedness.Infection2026https://conductscience.org/library/papers/42579070PubMed
4075286925 Years of Ebola Virus VP35 Research.J Mol Biol2025https://conductscience.org/library/papers/40752869PubMed
39858595The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.Genes (Basel)2025https://conductscience.org/library/papers/39858595PubMed
39386170Aptamers: precision tools for diagnosing and treating infectious diseases.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/39386170PubMed
37632081Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library.Viruses2023https://conductscience.org/library/papers/37632081PubMed
33734027Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.Virulence2021https://conductscience.org/library/papers/33734027PubMed
33408171Transcriptional Analysis of Lymphoid Tissues from Infected Nonhuman Primates Reveals the Basis for Attenuation and Immunogenicity of an Ebola Virus Encoding a Mutant VP35 Protein.J Virol2021https://conductscience.org/library/papers/33408171PubMed
32992829To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity.Microorganisms2020https://conductscience.org/library/papers/32992829PubMed
32493824Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.J Virol2020https://conductscience.org/library/papers/32493824PubMed
31744306Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.Antivir Chem Chemother2019https://conductscience.org/library/papers/31744306PubMed
31155428Ebola Virus Replication Stands Out.Trends Microbiol2019https://conductscience.org/library/papers/31155428PubMed
31066445Ebola virus VP35 has novel NTPase and helicase-like activities.Nucleic Acids Res2019https://conductscience.org/library/papers/31066445PubMed
29568066Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism.Emerg Microbes Infect2018https://conductscience.org/library/papers/29568066PubMed
29375139Post-exposure treatments for Ebola and Marburg virus infections.Nat Rev Drug Discov2018https://conductscience.org/library/papers/29375139PubMed
28566377Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus.J Virol2017https://conductscience.org/library/papers/28566377PubMed
27642076In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors.Bioorg Med Chem2016https://conductscience.org/library/papers/27642076PubMed
26876165Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.Cell Rep2016https://conductscience.org/library/papers/26876165PubMed
26172225Development of Small-Molecule Antivirals for Ebola.Med Res Rev2015https://conductscience.org/library/papers/26172225PubMed

See all 33 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21178490

GET https://conductscience.org/api/papers/v1/21178490/references?page=2